Pharmacological Demonstration of the Additive Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Antagonism in Sodium Depleted Healthy Subjects

Enzyme Inhibition ◽

Healthy Subjects ◽

Additive Effects ◽

Converting Enzyme ◽

Additive Effects of Combined Angiotensin-Converting Enzyme Inhibition and Angiotensin II Antagonism on Blood Pressure and Renin Release in Sodium-Depleted Normotensives

Circulation ◽

10.1161/01.cir.92.4.825 ◽

1995 ◽

Vol 92 (4) ◽

pp. 825-834 ◽

Cited By ~ 143

Author(s):

Michel Azizi ◽

Gilles Chatellier ◽

Thanh-Tam Guyene ◽

Dalia Murieta-Geoffroy ◽

Joël Ménard

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Enzyme Inhibition ◽

Renin Release ◽

Additive Effects ◽

Converting Enzyme ◽

Modulation of arterial thrombosis by angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade

The American Journal of Cardiology ◽

10.1016/s0002-9149(98)00678-x ◽

1998 ◽

Vol 82 (9) ◽

pp. 53S-56S

Author(s):

Jawahar L. Mehta

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibition ◽

Arterial Thrombosis ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade

Journal of Human Hypertension ◽

10.1038/sj.jhh.1002101 ◽

2006 ◽

Vol 21 (1) ◽

pp. 20-27 ◽

Cited By ~ 136

Author(s):

P Dandona ◽

S Dhindsa ◽

H Ghanim ◽

A Chaudhuri

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibition ◽

Angiotensin Ii Receptor Blockade

Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical NG, NG-dimethylarginine in human essential hypertension1

American Journal of Hypertension ◽

10.1016/s0895-7061(02)02278-1 ◽

2002 ◽

Vol 15 (7) ◽

pp. 590-593 ◽

Cited By ~ 103

Author(s):

C DELLES ◽

M SCHNEIDER ◽

S JOHN ◽

M GEKLE ◽

R SCHMIEDER

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibition ◽

At1 Receptor ◽

Receptor Blockade ◽

Converting Enzyme ◽

Comparison of Angiotensin-Converting Enzyme Inhibition with Angiotensin II Receptor Antagonism in the Human Forearm

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199310000-00011 ◽

1993 ◽

Vol 22 (4) ◽

pp. 579-584 ◽

Cited By ~ 72

Author(s):

John R. Cockcroft ◽

David G. Sciberras ◽

Michael R. Goldberg ◽

James M. Ritter

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibition ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Receptor Antagonism ◽

Human Forearm ◽

Renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition

Clinics ◽

10.6061/clinics/2012(07)10 ◽

2012 ◽

Vol 67 (7) ◽

pp. 761-765 ◽

Cited By ~ 3

Author(s):

A Stein ◽

S Goldmeier ◽

S Voltolini ◽

E Setogutti ◽

C Feldman ◽

...

Keyword(s):

Oxygen Content ◽

Enzyme Inhibition ◽

Healthy Subjects ◽

Converting Enzyme ◽

Converting Enzyme Inhibition ◽

Renal Oxygen

Tu-P7:247 Angiotensin-converting enzyme inhibition reduces the activity of MMP while angiotensin II receptor blockade inhibits the MMP expression and activity

Atherosclerosis Supplements ◽

10.1016/s1567-5688(06)80951-7 ◽

2006 ◽

Vol 7 (3) ◽

pp. 239

Author(s):

H. Kurata ◽

N. Machida ◽

C. Yanagisawa ◽

Y. Kishimoto ◽

M. Hasegawa ◽

...

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibition ◽

Angiotensin Ii Receptor Blockade ◽

Expression And Activity

The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension

Journal of Hypertension ◽

10.1097/01.hjh.0000234124.94013.ac ◽

2006 ◽

Vol 24 (7) ◽

pp. 1419-1427 ◽

Cited By ~ 20

Author(s):

Teresa M Seccia ◽

Anna S Belloni ◽

Diego Guidolin ◽

Daniele Sticchi ◽

Gastone G Nussdorfer ◽

...

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibition ◽

Receptor Activation ◽

Converting Enzyme ◽

Bradykinin B2 Receptor ◽

Angiotensin-Converting Enzyme Inhibition Potentiates Angiotensin II Type 1 Receptor Effects on Renal Bradykinin and cGMP

Hypertension ◽

10.1161/01.hyp.38.2.183 ◽

2001 ◽

Vol 38 (2) ◽

pp. 183-186 ◽

Cited By ~ 45

Author(s):

Helmy M. Siragy ◽

Marc de Gasparo ◽

Mohamed El-Kersh ◽

Robert M. Carey

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibition ◽

Converting Enzyme ◽

Modulation of arterial thrombosis by angiotensin-converting enzyme inhibition and angiotensin II type 1-receptor blockade

The American Journal of Cardiology ◽

10.1016/s0002-9149(98)90436-2 ◽

1998 ◽

Vol 82 (10) ◽

pp. S53-S56

Author(s):

Jawahar L. Mehta

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibition ◽

Arterial Thrombosis ◽

Receptor Blockade ◽

Converting Enzyme ◽